SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005825
Filing Date
2022-04-20
Accepted
2022-04-20 07:00:45
Documents
12
Period of Report
2022-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K stro-20220418.htm   iXBRL 8-K 44390
  Complete submission text file 0000950170-22-005825.txt   162455

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20220418_lab.xml EX-101.LAB 13562
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20220418_pre.xml EX-101.PRE 11085
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20220418.xsd EX-101.SCH 2490
6 EXTRACTED XBRL INSTANCE DOCUMENT stro-20220418_htm.xml XML 4754
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 22836307
SIC: 2836 Biological Products, (No Diagnostic Substances)